NKNSF(NKNSF)
USD --+0.00%
Reward56Moderate
Risk31Moderate
📊75%Data
Thin -3% profit margin · 2.6% dividend yield
NKNSF
+0.0 · +0.00%
USD · PINK
NKNSF | Healthcare
Dividend King
Market Cap:1.17Bn
ℹ️
Reward Rating
56
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
31
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on NKNSF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is NKNSF?

engages in the manufacture and sale of dental, surgical, and general industrial products in Japan and internationally.

NKNSF · Verdict

Solid reward · moderate risk

NKNSF scores well on cash flow and volatility with no major weaknesses flagged in the model.

Based on 88% data coverage

NKNSF · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow79/100

    13% free-cash-flow margin

  • Volatility75/100

    Above average

  • Profitability69/100

    11% net margin · -2% ROE

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is NKNSF?

engages in the manufacture and sale of dental, surgical, and general industrial products in Japan and internationally. The company offers dental equipment and chairs; air turbines; contra-angles; therapeutic motors; home visit medical equipment; oral hygiene products; endotherapy; oral surgery; maintenance and autoclave products; and technical products. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.17B, and a P/E ratio of 30.7x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.17B
P/E Ratio30.6739
Dividend Yield2.58%
52 Week High30.8707
52 Week Low13.7626
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding83M
No. of Employees2,180
IndustryMedical Instruments & Supplies
ExchangePINK
Beta-0.024
CurrencyUSD · Reports in JPY